159 related articles for article (PubMed ID: 15655740)
1. Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile?
Low DE
Clin Infect Dis; 2005 Jan; 40(2):236-8. PubMed ID: 15655740
[No Abstract] [Full Text] [Related]
2. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news.
Low DE
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S228-33. PubMed ID: 16032557
[TBL] [Abstract][Full Text] [Related]
3. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
Fuller JD; Low DE
Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
[TBL] [Abstract][Full Text] [Related]
4. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
[TBL] [Abstract][Full Text] [Related]
5. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
Ferrara AM
Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of antibiotic-resistant Streptococcus pneumoniae strains in Far East Russia.
Martynova AV; Turcutyuicov VB
Int J Antimicrob Agents; 2004 Jun; 23(6):641-2. PubMed ID: 15194139
[No Abstract] [Full Text] [Related]
7. Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005.
Ip M; Chau SS; Chi F; Cheuk ES; Ma H; Lai RW; Chan PK
Antimicrob Agents Chemother; 2007 Jun; 51(6):2192-4. PubMed ID: 17371818
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
Le Hello S; Page S; Garin B
Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
[No Abstract] [Full Text] [Related]
9. Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutants.
Smith-Adam HJ; Nichol KA; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2005 Feb; 49(2):846-8. PubMed ID: 15673786
[TBL] [Abstract][Full Text] [Related]
10. Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States.
Pletz MW; McGee L; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2005 Feb; 49(2):779-80. PubMed ID: 15673766
[TBL] [Abstract][Full Text] [Related]
11. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
Morrissey I; Tillotson G
J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
[TBL] [Abstract][Full Text] [Related]
12. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
Simoens S; Verhaegen J; Laekeman G; Peetermans WE
Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
[TBL] [Abstract][Full Text] [Related]
13. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
[TBL] [Abstract][Full Text] [Related]
14. In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.
Pérez-Trallero E; Marimón JM; González A; Ercibengoa M; Larruskain J
Clin Infect Dis; 2005 Aug; 41(4):560-4. PubMed ID: 16028169
[TBL] [Abstract][Full Text] [Related]
15. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
Morrissey I; Colclough A; Northwood J
Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
[TBL] [Abstract][Full Text] [Related]
16. Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.
Etienne M; Croisier D; Charles PE; Lequeu C; Piroth L; Portier H; Drlica K; Chavanet P
J Infect Dis; 2004 Oct; 190(8):1472-5. PubMed ID: 15378440
[TBL] [Abstract][Full Text] [Related]
17. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-resistant Streptococcus pneumoniae, an emerging but unrecognized public health concern: is it time to resight the goalposts?
Ambrose PG; Bast D; Doern GV; Iannini PB; Jones RN; Klugman KP; Low DE
Clin Infect Dis; 2004 Nov; 39(10):1554-6; author reply 1556-7. PubMed ID: 15546106
[No Abstract] [Full Text] [Related]
19. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.
Adam HJ; Hoban DJ; Gin AS; Zhanel GG
Int J Antimicrob Agents; 2009 Jul; 34(1):82-5. PubMed ID: 19342204
[TBL] [Abstract][Full Text] [Related]
20. Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
Low DE
Clin Infect Dis; 2004 May; 38 Suppl 4():S357-62. PubMed ID: 15127370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
